We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New CPR Method Increases Survival Rate by 50%

By HospiMedica International staff writers
Posted on 23 Mar 2011
A cardiopulmonary resuscitation (CPR) technique that uses two external devices to increase blood circulation improves long-term survival rates with good brain function by 50%, claims a new study.

Researchers at the University of Minnesota Medical School (UMN; Duluth, USA) developed the new method, which combines two devices to create a greater vacuum in the chest, pumping blood to the heart and brain more effectively. More...
The first device, the ResQPump, consists of a suction cup that attaches to the patient's chest; it includes a handle to lift manually the chest after each compression, stimulating blood flow. The second device, the ResQPOD, is an impedance threshold device (ITD) that provides perfusion on demand (POD), by regulating pressures in the thorax during states of hypotension, preventing unnecessary air from entering the chest during CPR.

As the chest wall recoils, the vacuum in the thorax is greater; this enhanced vacuum pulls more blood back to the heart, doubling blood flow during CPR. The mechanism increases cardiac output, blood pressure, and survival rates. The resulting combination of devices causes the heart and brain to receive nearly three times more blood flow during each compression-decompression cycle, when compared to standard CPR. Patient ventilation and exhalation are not restricted in any way. The study detailing the technique and the results was published in the January 22, 2011, issue of the Lancet.

"The current method of CPR has saved countless lives and is an indispensable tool in emergency medicine, but we want to bring to light the potential of using this new dual device system in combination with compression-decompression,” said Demetris Yannopoulos, MD, an assistant professor of medicine, and research director of interventional cardiology. "This dual device system can not only increase survival rates, but can improve brain function after cardiac arrest.”

"We are moving from prehistoric times--relying only on our hands--to modern times, implementing tools to treat victims,” said Keith Lurie, MD, a professor of medicine and emergency medicine at UMN. "This advance is a product of collaboration between emergency medicine specialists, cardiologists, anesthesiologists, neurologists, and countless other professions. A multidisciplinary environment was absolutely necessary for our success.”

Both the ResQPump and the ResQPOD are manufactured by Advanced Circulatory Systems (Roseville, MN, USA).

Related Links:

University of Minnesota Medical School
Advanced Circulatory Systems




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.